Related Experiment Video

Updated: Oct 15, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

10.0K

The role of GTPase-activating protein ARHGAP26 in human cancers

Lingye Zhang1, Anni Zhou1, Shengtao Zhu1

  • 1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.

Molecular and Cellular Biochemistry
|October 30, 2021
PubMed

Insights

ARHGAP26 regulates tumor cell behavior by inhibiting Rho GTPases. This review explores its functions, mechanisms, and potential as a cancer treatment target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Rho GTPases are key regulators of tumor cell behavior.
  • ARHGAP26 (RhoA GTPase-activating protein 26) modulates Rho GTPase activity.
  • Dysregulation of ARHGAP26 is implicated in tumorigenesis.

Purpose of the Study:

  • To review the biological functions and molecular mechanisms of ARHGAP26 in various tumors.
  • To explore the potential clinical value of ARHGAP26 in cancer therapy.
  • To identify current challenges and future research directions.

Main Methods:

  • Literature review of ARHGAP26 in cancer.
  • Analysis of ARHGAP26's role in tumorigenesis and progression.
  • Examination of ARHGAP26's involvement in gene fusions and circular RNA.

Main Results:

  • ARHGAP26 acts as a GTPase-activating protein, inhibiting Rho GTPases.
  • ARHGAP26 influences tumor progression via abnormal fusion genes and circular RNA.
  • ARHGAP26 exhibits diverse roles across different tumor types.

Conclusions:

  • ARHGAP26 is a significant factor in cancer development and progression.
  • ARHGAP26 holds promise as a therapeutic target for cancer treatment.
  • Further research is needed to fully elucidate ARHGAP26's clinical utility.
Keywords:
ARHGAP26CancerGTPase-activating proteinRho GTPase

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.6K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.1K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.1K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K